Table 3.
Main adverse events
| Loxapine | Placebo | p Value | |
|---|---|---|---|
| Shock, n (%) | 5 (10) | 6 (15) | 0.54 |
| Unexplained fever, n (%) | 1 (2) | 0 (0) | 1.0 |
| Seizure, n (%) | 1 (2) | 0 (0) | 1.0 |
| Dyskinesia, n (%) | 0 | 0 |
Main adverse events
| Loxapine | Placebo | p Value | |
|---|---|---|---|
| Shock, n (%) | 5 (10) | 6 (15) | 0.54 |
| Unexplained fever, n (%) | 1 (2) | 0 (0) | 1.0 |
| Seizure, n (%) | 1 (2) | 0 (0) | 1.0 |
| Dyskinesia, n (%) | 0 | 0 |